HOOKIPA PHARMA INC(HOOK)

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership.

HOOK iron condor setups HOOK expected move HOOK IV rank history

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

Snapshot
$0.88
52-Week Range
$0.81 – $1.54
YTD
-1.62%
IV Rank (30D)
68.16
Straddle Price
$10.00
P/C Vol Ratio
0.60
Market Cap
$0.0B
Info
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834)
Exchange
OTC Link
Market Cap
$0.0B

HOOKIPA Pharma Inc is a clinical-stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. Its oncology portfolio targets oncoviral cancer antigens and next-generation antigens and includes two primary programs in development: eseba-vec (formerly HB-200) and HB-700. Eseba-vec is in clinical development for the treatment of Human Papillomavirus 16-positive (HPV16+) head and neck cancers. It also develops infectious disease therapies in par…

Price History
Seasonality
MonthAvg ReturnYears of Data
Jan -0.52% 16
Feb +1.89% 16
Mar -2.01% 16
Apr +8.72% 16
May +8.27% 16
Jun -6.53% 16
Jul -5.01% 15
Aug +3.49% 15
Sep -2.23% 15
Oct -5.48% 15
Nov -0.88% 15
Dec -3.92% 15
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators
SMA 20: $1.17
SMA 50: $1.14
SMA 200: $0.98
Current: $1.15
EMA 12: $1.16
EMA 26: $1.16
MACD: 0.0010 | Signal: -0.0068
BULLISH
ADX (14): 24.52
WEAK TREND
+DI: 7.68
−DI: 14.12
Momentum Oscillators
RSI (14): 48.74
NEUTRAL
Stoch %K: 48.48
Stoch %D: 47.47
Williams %R: -45.45
Volume & Volatility
BB Upper: $1.21
BB Lower: $1.13
NEUTRAL
OBV: 201,523
Vol SMA 20: 10,237
Vol ROC: -68.81%
ATR: $0.05
True Range: $0.05
HV 20: 26.9%
HV 30: 28.4%
HV 60: 28.1%
Data Summary
Data Points: 500
Last Updated: 2026-06-12T21:15:09.688000
Date Range: 2024-05-28T00:00:00 – 2026-06-02T00:00:00
AI Analysis

Choose Frenzy-Fast™ for quick analysis or Frenzy-Pro™ for comprehensive analysis.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

News
Earnings History
2 of 2 under expected move
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2024-08-08 Pre-Market 99.49% 3.27% 0.03x Within
2024-11-14 After-Close 22.73% 9.09% 0.40x Within
Options Activity
IV Rank (30D)
68.16
IV Rank (7D)
100
Avg IV
1098.8%
Straddle (30D)
$10.00
Straddle (7D)
$10.00
P/C Volume
0.60
Spread Scanner GPU
Full Algorithm Docs ↗

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score (GPU scanner)

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.

Stage 2 — Skew Adjustment (±25% cap)

RR25 and BF25 from the live options chain. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Enter a ticker to scan for optimal spread opportunities.

Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.

Volatility Surface

Enter a ticker to render the implied volatility surface.

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Beta (1Y vs SPY)
0.33
Correlation (SPY)
10.2%
R²
0.01
Ann. Volatility
38.6%
SPY Volatility
11.9%

Low volatility - stock moves less than market

Beta & Alpha Over Time
Institutional Ownership (13F)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

# Filer Shares Value % of Total % of Float Period
# Filer Notional Value % of Total Period
# Filer Notional Value % of Total Period
Insider Activity
Latest: 2025-07-23
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2025-07-23 Mary Theresa Coelho EVP and CFO Sell (S) −13,609 $0.92 -$12.5K EDGAR
2025-07-23 Malte Peters Chief Executive Officer Sell (S) −29,176 $0.92 -$26.8K EDGAR
2024-07-24 Mary Theresa Coelho EVP and CFO Award (A) +69,875 — EDGAR
2024-07-24 Malte Peters Chief Executive Officer Award (A) +108,695 — EDGAR
2024-07-24 Sean A Cassidy Director Grant (A) +9,800 opt — EDGAR
2024-06-18 Malte Peters Director Grant (A) +49,000 opt — EDGAR
2024-06-18 Mary Theresa Coelho Director Grant (A) +49,000 opt — EDGAR
2024-06-18 Winkel Jan van de Director Grant (A) +98,000 opt — EDGAR
2024-06-18 David Ross Kaufman Director Grant (A) +49,000 opt — EDGAR
2024-06-18 Timothy P. Reilly Director Grant (A) +49,000 opt — EDGAR
2024-06-18 Julie O'Neill Director Grant (A) +49,000 opt — EDGAR
2024-04-17 Klaus Orlinger Chief Scientific Officer Grant (A) +367,300 opt — EDGAR
2024-04-17 Roman Necina Chief Operations Officer Grant (A) +367,300 opt — EDGAR
2024-04-17 Reinhard Kandera Chief Financial Officer Grant (A) +406,200 opt — EDGAR
2024-04-17 Jorn Aldag Chief Executive Officer Grant (A) +971,400 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
Insider Holdings
38 insiders · @ $1.15
Officers, directors, and 10%+ owners ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 ANHEUSER-BUSCH COMPANIES, INC. Director 6,069,047 $6.98M $0 1 2008-07-01
2 Sofinnova Partners SAS 10%+ Owner 3,578,194 $4.11M $1.77M 5 2021-03-29
3 SOFINNOVA CAPITAL VI FCPR 10%+ Owner 3,177,574 $3.65M -$12.29M 10 2021-04-23
4 Forbion Capital Fund II Cooperatief U.A. 10%+ Owner 2,440,602 $2.81M $750.0K 1 2019-04-25
5 Ann G Widmer 10%+ Owner 1,876,781 $2.16M -$1.08M 7 2010-10-15
6 Kurt R Widmer Director 1,749,281 $2.01M -$1.54M 15 2011-06-15
7 Redmile Group, LLC 10%+ Owner 999,322 $1.15M $0 1 2019-04-24
8 BAKER BROS. ADVISORS LP 820,729 $943.8K $50.00M 1 2019-04-23
9 TIMOTHY P BOYLE Director 463,354 $532.9K $0 4 2011-05-26
10 FRANK H CLEMENT Director 221,780 $255.0K $0 2 2008-06-26
11 PAUL S SHIPMAN Chief Executive Officer 160,800 $184.9K $0 1 2007-05-24
12 Igor Matushansky Chief Medical Officer 100,240 $115.3K -$633.7K 12 2022-07-01
13 Malte Peters Chief Executive Officer 79,519 $91.4K -$26.8K 4 2025-07-23
14 Jorn Aldag Chief Executive Officer 71,952 $82.7K $17.1K 12 2024-04-17
15 Mary Theresa Coelho EVP and CFO 56,266 $64.7K -$12.5K 4 2025-07-23
16 DAVID J MICKELSON President & COO 47,000 $54.0K $0 1 2007-05-24
17 V Sebastian Pastore EVP, Brewing Operations & Log 43,600 $50.1K $102.4K 8 2011-09-07
18 Reinhard Kandera Chief Financial Officer 43,092 $49.6K $21.3K 12 2024-04-17
19 Terry E Michaelson Chief Executive Officer 25,299 $29.1K $27.9K 8 2011-05-27
20 Kevin R Kelly Director 24,694 $28.4K -$36.3K 5 2011-05-26
21 DAVID R LORD Director 19,284 $22.2K $20.1K 8 2011-08-26
22 Mark D Moreland Chief Financial Officer 16,400 $18.9K $70.3K 8 2011-11-22
23 Christine D. Baker Chief Operating Officer 16,158 $18.6K $0 5 2023-04-18
24 John D JR Rogers Director 15,634 $18.0K -$18.8K 7 2011-05-26
25 Roman Necina Chief Operations Officer 14,876 $17.1K $0 9 2024-04-17
26 Michael Loughran Director 12,040 $13.8K $0 2 2008-06-26
27 Klaus Orlinger Chief Scientific Officer 10,404 $12.0K -$197.4K 11 2024-04-17
28 Winkel Jan van de Director 9,153 $10.5K $0 7 2024-06-18
29 Andrew R Goeler Director 8,694 $10.0K $0 3 2011-05-26
30 ANTHONY J SHORT Director 6,000 $6.9K $0 3 2010-05-26
31 Michael Aaron Kelly Director 5,754 $6.6K $0 5 2022-07-01
32 Julie O'Neill Director 4,969 $5.7K $0 8 2024-06-18
33 Graziano Seghezzi Director 4,708 $5.4K $0 5 2021-06-04
34 Christoph Lengauer Director 4,603 $5.3K $0 5 2021-06-04
35 David Ross Kaufman Director 4,577 $5.3K $0 7 2024-06-18
36 Marc J Cramer Director 3,894 $4.5K $7.0K 2 2011-08-18
37 Sander van Deventer Director 2,485 $2.9K $0 4 2020-10-23
38 Martin J IV Wall Vice President, Sales 1,597 $1.8K $5.7K 7 2011-08-24
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
ETF Holders
# ETF Provider Weight $ Exposure ETF AUM As Of
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.